{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04379596",
            "orgStudyIdInfo": {
                "id": "D967LC00001"
            },
            "secondaryIdInfos": [
                {
                    "id": "2019-004483-22",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "AstraZeneca",
                "class": "INDUSTRY"
            },
            "briefTitle": "Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)",
            "officialTitle": "A Phase 1b/2 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of Trastuzumab Deruxtecan (T-DXd) Monotherapy and Combinations in Adult Participants With HER2-expressing Gastric Cancer (DESTINY-Gastric-03)",
            "acronym": "DG-03",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "study-of-the-safety-and-efficacy-of-t-dxd-combinations-in-advanced-expressing-gastric-cancer-destiny"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-06-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-07-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-05-05",
            "studyFirstSubmitQcDate": "2020-05-05",
            "studyFirstPostDateStruct": {
                "date": "2020-05-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "AstraZeneca",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Daiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, Tokyo",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "DESTINY-Gastric03 will investigate the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of trastuzumab deruxtecan (T-DXd) alone or in combination with chemotherapy and/or immunotherapy in HER2-expressing advanced/metastatic gastric/gastroesophageal junction (GEJ) and esophageal adenocarcinoma patients.\n\nStudy hypotheses: Combination of T-DXd with cytotoxic chemotherapy and/or immunotherapy administered to subjects at the recommended phase 2 dose will show manageable safety and tolerability and preliminary anti-tumor efficacy so as to permit further clinical testing. T-DXd in combination with cytotoxic chemotherapy or immune checkpoint inhibitor administered to HER2-expressing gastric, GEJ and esophageal cancer patients who have not received prior treatment for advanced/metastatic disease will show preliminary evidence of anti-tumour activity and the potential to become a therapeutic option for this patient population."
        },
        "conditionsModule": {
            "conditions": [
                "Gastric Cancer"
            ],
            "keywords": [
                "Gastric Cancer",
                "Esophageal Cancer",
                "Carcinoma",
                "HER2",
                "Trastuzumab",
                "Deruxtecan",
                "T-DXd",
                "DS-8201a",
                "Gastroesophageal Cancer",
                "Adenocarcinoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "The study will consist of 2 phases: a dose escalation phase (Part 1) and dose expansion phases (Part 2, Part 3 and Part 4). Part 1 will enroll HER2-overexpressing (IHC 3+ or IHC 2+/ISH+), previously treated gastric, gastro-esophageal junction (GEJ) or esophageal cancer patients, and Part 2 will enroll HER2-overexpressing patients who have not received prior treatment for metastatic or unresectable disease. Part 3 and Part 4 will enroll HER2-expressing patients who have not received prior treatment for metastatic or unresectable disease.\n\nIn addition to safety and tolerability, this study will also assess ORR, DoR, DCR, OS, PFS and other measures of antitumor activity among treatment groups. Tumor evaluation using RECIST v1.1 will be conducted at screening and every 6 weeks until RECIST 1.1 objective disease progression or withdrawal of consent.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 413,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm 1A",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd and 5-fluorouracil (5-FU)",
                    "interventionNames": [
                        "Drug: Fluorouracil (5-FU)",
                        "Drug: Trastuzumab deruxtecan"
                    ]
                },
                {
                    "label": "Arm 1B",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd and capecitabine",
                    "interventionNames": [
                        "Drug: Capecitabine",
                        "Drug: Trastuzumab deruxtecan"
                    ]
                },
                {
                    "label": "Arm 1C",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd and durvalumab",
                    "interventionNames": [
                        "Biological: Durvalumab",
                        "Drug: Trastuzumab deruxtecan"
                    ]
                },
                {
                    "label": "Arm 1D(b)",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd, capecitabine, and oxaliplatin",
                    "interventionNames": [
                        "Drug: Capecitabine",
                        "Drug: Oxaliplatin",
                        "Drug: Trastuzumab deruxtecan"
                    ]
                },
                {
                    "label": "Arm 1E(a)",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd, 5-FU, and durvalumab",
                    "interventionNames": [
                        "Drug: Fluorouracil (5-FU)",
                        "Biological: Durvalumab",
                        "Drug: Trastuzumab deruxtecan"
                    ]
                },
                {
                    "label": "Arm 1E(b)",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd, capecitabine, and durvalumab",
                    "interventionNames": [
                        "Drug: Capecitabine",
                        "Biological: Durvalumab",
                        "Drug: Trastuzumab deruxtecan"
                    ]
                },
                {
                    "label": "Arm 2A",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Trastuzumab, 5-FU or capecitabine, and cisplatin or oxaliplatin",
                    "interventionNames": [
                        "Drug: Fluorouracil (5-FU)",
                        "Drug: Capecitabine",
                        "Drug: Oxaliplatin",
                        "Biological: Trastuzumab",
                        "Drug: Cisplatin"
                    ]
                },
                {
                    "label": "Arm 2B",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd monotherapy",
                    "interventionNames": [
                        "Drug: Trastuzumab deruxtecan"
                    ]
                },
                {
                    "label": "Arm 2C",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd, 5-FU or capecitabine",
                    "interventionNames": [
                        "Drug: Fluorouracil (5-FU)",
                        "Drug: Capecitabine",
                        "Drug: Trastuzumab deruxtecan"
                    ]
                },
                {
                    "label": "Arm 2D",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd, pembrolizumab and 5-FU or capecitabine",
                    "interventionNames": [
                        "Drug: Fluorouracil (5-FU)",
                        "Drug: Capecitabine",
                        "Drug: Trastuzumab deruxtecan",
                        "Biological: Pembrolizumab"
                    ]
                },
                {
                    "label": "Arm 2E",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd and pembrolizumab",
                    "interventionNames": [
                        "Drug: Trastuzumab deruxtecan",
                        "Biological: Pembrolizumab"
                    ]
                },
                {
                    "label": "Arm 2F",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd, pembrolizumab and 5-FU or capecitabine",
                    "interventionNames": [
                        "Drug: Fluorouracil (5-FU)",
                        "Drug: Capecitabine",
                        "Drug: Trastuzumab deruxtecan",
                        "Biological: Pembrolizumab"
                    ]
                },
                {
                    "label": "Arm 3A",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd, Volrustomig and 5-FU or capecitabine",
                    "interventionNames": [
                        "Drug: Fluorouracil (5-FU)",
                        "Drug: Capecitabine",
                        "Drug: Trastuzumab deruxtecan",
                        "Biological: Volrustomig"
                    ]
                },
                {
                    "label": "Arm 3B",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd, Volrustomig and 5-FU or capecitabine",
                    "interventionNames": [
                        "Drug: Fluorouracil (5-FU)",
                        "Drug: Capecitabine",
                        "Drug: Trastuzumab deruxtecan",
                        "Biological: Volrustomig"
                    ]
                },
                {
                    "label": "Arm 4A",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd, Rilvegostomig and 5-FU or capecitabine",
                    "interventionNames": [
                        "Drug: Fluorouracil (5-FU)",
                        "Drug: Capecitabine",
                        "Drug: Trastuzumab deruxtecan",
                        "Biological: Rilvegostomig"
                    ]
                },
                {
                    "label": "Arm 4B",
                    "type": "EXPERIMENTAL",
                    "description": "T-DXd, Rilvegostomig and 5-FU or capecitabine",
                    "interventionNames": [
                        "Drug: Fluorouracil (5-FU)",
                        "Drug: Capecitabine",
                        "Drug: Trastuzumab deruxtecan",
                        "Biological: Rilvegostomig"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Fluorouracil (5-FU)",
                    "description": "5-FU: administered as an IV infusion",
                    "armGroupLabels": [
                        "Arm 1A",
                        "Arm 1E(a)",
                        "Arm 2A",
                        "Arm 2C",
                        "Arm 2D",
                        "Arm 2F",
                        "Arm 3A",
                        "Arm 3B",
                        "Arm 4A",
                        "Arm 4B"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Capecitabine",
                    "description": "Capecitabine: administered orally",
                    "armGroupLabels": [
                        "Arm 1B",
                        "Arm 1D(b)",
                        "Arm 1E(b)",
                        "Arm 2A",
                        "Arm 2C",
                        "Arm 2D",
                        "Arm 2F",
                        "Arm 3A",
                        "Arm 3B",
                        "Arm 4A",
                        "Arm 4B"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Durvalumab",
                    "description": "Durvalumab: administered as an IV infusion",
                    "armGroupLabels": [
                        "Arm 1C",
                        "Arm 1E(a)",
                        "Arm 1E(b)"
                    ],
                    "otherNames": [
                        "MEDI4736"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Oxaliplatin",
                    "description": "Oxaliplatin: administered as an IV infusion",
                    "armGroupLabels": [
                        "Arm 1D(b)",
                        "Arm 2A"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Trastuzumab",
                    "description": "Trastuzumab: administered as an IV infusion",
                    "armGroupLabels": [
                        "Arm 2A"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Trastuzumab deruxtecan",
                    "description": "T-DXd: administered as an IV infusion",
                    "armGroupLabels": [
                        "Arm 1A",
                        "Arm 1B",
                        "Arm 1C",
                        "Arm 1D(b)",
                        "Arm 1E(a)",
                        "Arm 1E(b)",
                        "Arm 2B",
                        "Arm 2C",
                        "Arm 2D",
                        "Arm 2E",
                        "Arm 2F",
                        "Arm 3A",
                        "Arm 3B",
                        "Arm 4A",
                        "Arm 4B"
                    ],
                    "otherNames": [
                        "DS-8201a"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cisplatin",
                    "description": "Cisplatin: administered as an IV infusion",
                    "armGroupLabels": [
                        "Arm 2A"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Pembrolizumab",
                    "description": "Pembrolizumab: administered as an IV infusion",
                    "armGroupLabels": [
                        "Arm 2D",
                        "Arm 2E",
                        "Arm 2F"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Volrustomig",
                    "description": "Volrustomig: administered as an IV infusion",
                    "armGroupLabels": [
                        "Arm 3A",
                        "Arm 3B"
                    ],
                    "otherNames": [
                        "MEDI5752"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Rilvegostomig",
                    "description": "Rilvegostomig: administered as an IV infusion",
                    "armGroupLabels": [
                        "Arm 4A",
                        "Arm 4B"
                    ],
                    "otherNames": [
                        "AZD2936"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Part 1: Occurrence of adverse events (AEs) and serious adverse events (SAEs), graded according to NCI CTCAE v5.0",
                    "description": "Occurrence of AEs and SAEs graded according to NCI CTCAE v5.0",
                    "timeFrame": "Safety will be assessed up to the follow-up period, approximately 24 months."
                },
                {
                    "measure": "Part 1: Ocurrence of dose-limiting toxicities (DLTs)",
                    "description": "Occurrence of dose limiting toxicities",
                    "timeFrame": "Safety will be assessed up to the follow-up period, approximately 24 months."
                },
                {
                    "measure": "Part 1: Changes from baseline in laboratory parameters",
                    "description": "Changes in laboratory parameters (every in appropriate units) compared to baseline results.",
                    "timeFrame": "Safety will be assessed up to the follow-up period, approximately 24 months."
                },
                {
                    "measure": "Part 1: Changes from baseline in vital signs",
                    "description": "Changes in vital signs results compared to baseline results.",
                    "timeFrame": "Safety will be assessed up to the follow-up period, approximately 24 months."
                },
                {
                    "measure": "Part 1: Changes from baseline in electrocardiogram (ECG) results",
                    "description": "Changes in ECG results compared to baseline results.",
                    "timeFrame": "Safety will be assessed up to the follow-up period, approximately 24 months."
                },
                {
                    "measure": "Part 2, Part 3 and Part 4: Endpoint assessed by Investigator per RECIST v1.1: Confirmed Objective Response Rate (ORR)",
                    "description": "Confirmed ORR per RECIST 1.1 is the percentage of patients with Complete Response or Partial Response that is subsequently confirmed.",
                    "timeFrame": "(Endpoint: ORR) Efficacy will be assessed at an average of approximately 12 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Part 1: Objective Response Rate (ORR)",
                    "description": "Confirmed ORR per RECIST 1.1 is the percentage of patients with Complete Response or Partial Response that is subsequently confirmed.",
                    "timeFrame": "Efficacy will be assessed at an average of approximately 12 months"
                },
                {
                    "measure": "Part 2, Part 3 and Part 4: Occurrence of adverse events (AEs) and serious adverse events (SAEs)",
                    "description": "Occurrence of AEs and SAEs graded according to NCI CTCAE v5.0",
                    "timeFrame": "Safety will be assessed up to follow-up period, approximately 24 months"
                },
                {
                    "measure": "Part 2, Part 3 and Part 4: Changes from baseline in laboratory parameters",
                    "description": "Changes in laboratory parameters (every in appropriate units) compared to baseline results.",
                    "timeFrame": "Safety will be assessed up to follow-up period, approximately 24 months"
                },
                {
                    "measure": "Part 2, Part 3 and Part 4: Changes from baseline in vital signs",
                    "description": "Changes in vital signs results compared to baseline results.",
                    "timeFrame": "Safety will be assessed up to follow-up period, approximately 24 months"
                },
                {
                    "measure": "Part 2, Part 3 and Part 4: Changes from baseline in body weight",
                    "description": "Changes in body weight in kilograms compared to baseline results.",
                    "timeFrame": "Safety will be assessed up to follow-up period, approximately 24 months"
                },
                {
                    "measure": "Part 2, Part 3 and Part 4: Changes from baseline in electrocardiogram (ECG) results",
                    "description": "Changes in ECG results compared to baseline results.",
                    "timeFrame": "Safety will be assessed up to follow-up period, approximately 24 months"
                },
                {
                    "measure": "Duration of Response (DoR)",
                    "description": "DOR is defined as the time from the date of first documented response until the date of documented progression or death",
                    "timeFrame": "Until progression or death, efficacy (DoR) will be assessed up to approximately 24 months"
                },
                {
                    "measure": "Disease Control Rate (DCR)",
                    "description": "DCR is the percentage of subjects who have a best overall response of complete response (CR) or partial response (PR) or stable disease (SD)",
                    "timeFrame": "Efficacy will be assessed at an average of approximately 12 months"
                },
                {
                    "measure": "Progression Free Survival (PFS)",
                    "description": "PFS is the time from date of first dose until the date of objective disease progression or death",
                    "timeFrame": "Until progression or death, efficacy (PFS) will be assessed up to approximately 24 months"
                },
                {
                    "measure": "Overall survival (OS)",
                    "description": "OS is the time from date of first dose until death due to any cause",
                    "timeFrame": "Until death, efficacy (OS) will be assessed up to approximately 24 months"
                },
                {
                    "measure": "Serum concentration of T-DXd, total anti-HER2 antibody, and MAAA-1181a in all arms",
                    "description": "Individual participant data and descriptive statistics will be provided for serum concentration data at each time point for each dose level for T-DXd, total anti-HER2 antibody, MAAA-1181a",
                    "timeFrame": "While on study drug up to study completion, approximately 24 months"
                },
                {
                    "measure": "Serum concentration of durvalumab in study arms including T-DXd in combination with durvalumab",
                    "description": "Individual participant data and descriptive statistics will be provided for serum concentration data at each time point for durvalumab.",
                    "timeFrame": "While on study drug up to study completion, approximately 24 months"
                },
                {
                    "measure": "Presence of ADAs for T-DXD, durvalumab, volrustomig and rilvegostomig (in study arms including T-DXd and durvalumab, and T-DXd and volrustomig, and T-DXd and rilvegostomig respectively)",
                    "description": "Individual participant data and descriptive statistics will be provided for data at each time point for each dose level for T-DXd and durvalumab.",
                    "timeFrame": "While on study drug up to study completion, approximately 24 months"
                },
                {
                    "measure": "Serum concentrations of volrustomig and rilvegostomig in study arms including T-DXd in combination with volrustomig and T-DXd in combination with rilvegostomig",
                    "description": "Individual participant data and descriptive statistics will be provided for data at each time point for rilvegostomig and volrustomig",
                    "timeFrame": "While on study drug up to study completion, approximately 24 months"
                },
                {
                    "measure": "Comparison of ORR",
                    "description": "Comparison of objective response rate between participants using local HER2 test results and central HER2 test results from tumor samples with evaluable results",
                    "timeFrame": "While on study drug up to study completion, approximately 24 months"
                },
                {
                    "measure": "Comparison of DCR",
                    "description": "Comparison of disease control rate between participants using local HER2 test results and central HER2 test results from tumor samples with evaluable results",
                    "timeFrame": "While on study drug up to study completion, approximately 24 months"
                },
                {
                    "measure": "Comparison of DoR",
                    "description": "Comparison of duration of response between participants using local HER2 test results and central HER2 test results from tumor samples with evaluable results",
                    "timeFrame": "While on study drug up to study completion, approximately 24 months"
                },
                {
                    "measure": "Comparison of PFS",
                    "description": "Comparison of progression-free survival between participants using local HER2 test results and central HER2 test results from tumor samples with evaluable results",
                    "timeFrame": "While on study drug up to study completion, approximately 24 months"
                },
                {
                    "measure": "Comparison of OS",
                    "description": "Comparison of overall survival between participants using local HER2 test results and central HER2 test results from tumor samples with evaluable results",
                    "timeFrame": "While on study drug up to study completion, approximately 24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion criteria:\n\n1. Male and female participants must be at least 18 years of age. Other age restrictions may apply as per local regulations\n2. Disease Characteristics:\n\n   1. Locally advanced, unresectable, or metastatic disease based on most recent imaging\n   2. For Part 1, 2, 3a, 4a pathologically documented adenocarcinoma of the stomach/GEJ/esophagus, HER2-positive (IHC 3+ or IHC 2+/ISH+) based on local tissue testing results\n   3. For Part 3b and 4b, pathologically documented adenocarcinoma of the stomach/GEJ/esophagus, HER2-low (IHC 2+/ISH-negative or IHC 1+) based on local tissue testing results\n3. For Part 1, progression on or after at least one prior trastuzumabcontaining regimen For Part 2, Part 3 and Part 4, previously untreated for unresectable or metastatic adenocarcinoma of the stomach/GEJ/ esophagus with with HER2-positive (Part 2 and Part 3 \\[Arm 3A\\] and Part 4 \\[Arm 4A\\]) or HER2-low (Part 3 \\[Arm 3B\\] and Part 4 \\[Arm 4B\\])) status\n4. Has measurable target disease assessed by the Investigator based on RECIST version 1.1\n5. Has protocol defined adequate bone marrow and organ function including cardiac, renal and hepatic function\n6. If of reproductive potential, agrees to use a highly effective form of contraception or avoid intercourse during and upon completion of the study.\n\nExclusion criteria:\n\n1. History of active primary immunodeficiency, known HIV, active chronic, or past hepatitis B infection, or hepatitis C infection.\n2. Uncontrolled intercurrent illness\n3. History of non-infectious pneumonitis/ILD, current ILD, or where suspected ILD that cannot be ruled out by imaging at screening.\n4. Lung-specific intercurrent clinically significant severe illnesses.\n5. Uncontrolled infection requiring intravenous (IV) antibiotics, antivirals, or antifungals.\n6. Pleural effusion, ascites or pericardial effusion that requires drainage, peritoneal shunt, or Cell-free and Concentrated Ascites Reinfusion Therapy (CART).\n7. Has spinal cord compression or clinically active central nervous system metastases.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "130 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "AstraZeneca Clinical Study Information Center",
                    "role": "CONTACT",
                    "phone": "1-877-240-9479",
                    "email": "information.center@astrazeneca.com"
                }
            ],
            "locations": [
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Santa Monica",
                    "state": "California",
                    "zip": "90404",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.01945,
                        "lon": -118.49119
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Westwood",
                    "state": "Kansas",
                    "zip": "66205",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.04056,
                        "lon": -94.6169
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21287",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77090",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Florianopolis",
                    "zip": "88020-210",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -27.59667,
                        "lon": -48.54917
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Londrina",
                    "zip": "86015-520",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -23.31028,
                        "lon": -51.16278
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Natal",
                    "zip": "59075-740",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -5.795,
                        "lon": -35.20944
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Porto Alegre",
                    "zip": "90160-093",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -30.03306,
                        "lon": -51.23
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Ribeir\u00e3o Preto",
                    "zip": "14051-140",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -21.1775,
                        "lon": -47.81028
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Rio de Janeiro",
                    "zip": "22793-080",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -22.90278,
                        "lon": -43.2075
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Santa Maria",
                    "zip": "97015-450",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -29.68417,
                        "lon": -53.80694
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Sao Paulo",
                    "zip": "01509-900",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -23.5475,
                        "lon": -46.63611
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "S\u00e3o Jose do Rio Preto",
                    "zip": "15090-000",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -20.81972,
                        "lon": -49.37944
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "S\u00e3o Paulo",
                    "zip": "03102-002",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -23.5475,
                        "lon": -46.63611
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "S\u00e3o Paulo",
                    "zip": "045202-001",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -23.5475,
                        "lon": -46.63611
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G 1Z2",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Ottawa",
                    "state": "Ontario",
                    "zip": "K1H 8L6",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.41117,
                        "lon": -75.69812
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M4N 3M5",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5G 2M9",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Montreal",
                    "state": "Quebec",
                    "zip": "H4A 3J1",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Quebec",
                    "zip": "G1J 1Z4",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 46.81228,
                        "lon": -71.21454
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Chengdu",
                    "zip": "610042",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.66667,
                        "lon": 104.06667
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Guangzhou",
                    "zip": "510062",
                    "country": "China",
                    "geoPoint": {
                        "lat": 23.11667,
                        "lon": 113.25
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Guiyang",
                    "zip": "550002",
                    "country": "China",
                    "geoPoint": {
                        "lat": 26.58333,
                        "lon": 106.71667
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Hangzhou",
                    "zip": "310022",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.29365,
                        "lon": 120.16142
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Hefei",
                    "zip": "230001",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.86389,
                        "lon": 117.28083
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Hefei",
                    "zip": "230601",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.86389,
                        "lon": 117.28083
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Shanghai",
                    "zip": "200031",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "zip": "200032",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Shanghai",
                    "zip": "200050",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Urumqi",
                    "zip": "830000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 43.80096,
                        "lon": 87.60046
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Wuhan",
                    "zip": "430000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.58333,
                        "lon": 114.26667
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Xiamen",
                    "zip": "361003",
                    "country": "China",
                    "geoPoint": {
                        "lat": 24.47979,
                        "lon": 118.08187
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Zhengzhou",
                    "zip": "450008",
                    "country": "China",
                    "geoPoint": {
                        "lat": 34.75778,
                        "lon": 113.64861
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Frankfurt",
                    "zip": "60488",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.11552,
                        "lon": 8.68417
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Frankfurt",
                    "zip": "60590",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.11552,
                        "lon": 8.68417
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Hamburg",
                    "zip": "20249",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 53.57532,
                        "lon": 10.01534
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Leipzig",
                    "zip": "04103",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.33962,
                        "lon": 12.37129
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Mannheim",
                    "zip": "68167",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 49.4891,
                        "lon": 8.46694
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "M\u00fcnchen",
                    "zip": "81675",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 48.13743,
                        "lon": 11.57549
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "zip": "20133",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "zip": "20162",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Napoli",
                    "zip": "80131",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Padova",
                    "zip": "35128",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.40797,
                        "lon": 11.88586
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "zip": "00168",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Verona",
                    "zip": "37134",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.4299,
                        "lon": 10.98444
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Chuo-ku",
                    "zip": "104-0045",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.57779,
                        "lon": 139.71685
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Kashiwa",
                    "zip": "277-8577",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.86224,
                        "lon": 139.97732
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Kita-gun",
                    "zip": "761-0793",
                    "country": "Japan"
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Ota-shi",
                    "zip": "373-8550",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 36.3,
                        "lon": 139.36667
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Seongnam-si",
                    "zip": "13620",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.43861,
                        "lon": 127.13778
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "05505",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "06351",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Amsterdam",
                    "zip": "1066CX",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 52.37403,
                        "lon": 4.88969
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Amsterdam",
                    "zip": "1081 HV",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 52.37403,
                        "lon": 4.88969
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Utrecht",
                    "zip": "3584CG",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 52.09083,
                        "lon": 5.12222
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Gda\u0144sk",
                    "zip": "80-214",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 54.35205,
                        "lon": 18.64637
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Konin",
                    "zip": "62-500",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 52.22338,
                        "lon": 18.25121
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Koszalin",
                    "zip": "75-581",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 54.19438,
                        "lon": 16.17222
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Krak\u00f3w",
                    "zip": "31-501",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 50.06143,
                        "lon": 19.93658
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Lublin",
                    "zip": "20-090",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 51.25,
                        "lon": 22.56667
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Opole",
                    "zip": "45-061",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 50.67211,
                        "lon": 17.92533
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Tomasz\u00f3w Mazowiecki",
                    "zip": "97-200",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 51.53131,
                        "lon": 20.00855
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Warszawa",
                    "zip": "02-034",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "SUSPENDED",
                    "city": "Kostroma",
                    "zip": "156005",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 57.76647,
                        "lon": 40.92686
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "SUSPENDED",
                    "city": "Moscow",
                    "zip": "115478",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.75222,
                        "lon": 37.61556
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "TERMINATED",
                    "city": "Moscow",
                    "zip": "125284",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.75222,
                        "lon": 37.61556
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "SUSPENDED",
                    "city": "Moscow",
                    "zip": "143423",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.75222,
                        "lon": 37.61556
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "TERMINATED",
                    "city": "Moscow",
                    "zip": "143442",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.75222,
                        "lon": 37.61556
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "SUSPENDED",
                    "city": "Novosibirsk",
                    "zip": "630099",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.0415,
                        "lon": 82.9346
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "COMPLETED",
                    "city": "Saint Petersburg",
                    "zip": "195271",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 59.93863,
                        "lon": 30.31413
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "SUSPENDED",
                    "city": "Saint-Petersburg",
                    "zip": "197022",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 59.93863,
                        "lon": 30.31413
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "SUSPENDED",
                    "city": "Saint-Petersburg",
                    "zip": "197758",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 59.93863,
                        "lon": 30.31413
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "SUSPENDED",
                    "city": "Sankt-Peterburg",
                    "zip": "196603",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 59.93863,
                        "lon": 30.31413
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28007",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28034",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Santander",
                    "zip": "39008",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 43.46472,
                        "lon": -3.80444
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Sevilla",
                    "zip": "41013",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 37.38283,
                        "lon": -5.97317
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Kaohsiung",
                    "zip": "80756",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 22.61626,
                        "lon": 120.31333
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "WITHDRAWN",
                    "city": "Kaohsiung",
                    "zip": "83301",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 22.61626,
                        "lon": 120.31333
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Tainan",
                    "zip": "704",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 22.99083,
                        "lon": 120.21333
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "zip": "10002",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "zip": "11217",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Taoyuan",
                    "zip": "333",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.95233,
                        "lon": 121.20193
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Cambridge",
                    "zip": "CB2 0QQ",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 52.2,
                        "lon": 0.11667
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Dundee",
                    "zip": "DD1 9SY",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 56.46913,
                        "lon": -2.97489
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "NW1 2PG",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Manchester",
                    "zip": "M20 4BX",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Sutton",
                    "zip": "SM2 5PT",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.35,
                        "lon": -0.2
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal.\n\nAll request will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.",
            "infoTypes": [
                "ICF"
            ],
            "timeFrame": "Study start to completion date",
            "accessCriteria": "When a request has been approved AstraZeneca will provide access to the de-identified individual patient-level data in an approved sponsored tool .\n\nSigned Data Sharing Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information. Additionally, all users will need to accept the terms and conditions of the SAS MSE to gain access.\n\nFor additional details, please review the Disclosure Statements at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.",
            "url": "https://astrazenecagroup-dt.pharmacm.com/DT/Home"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013274",
                    "term": "Stomach Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000013272",
                    "term": "Stomach Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M16064",
                    "name": "Stomach Neoplasms",
                    "asFound": "Gastric Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8088",
                    "name": "Esophageal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16062",
                    "name": "Stomach Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5486",
                    "name": "Stomach Cancer",
                    "asFound": "Gastric Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2141",
                    "name": "Esophageal Cancer",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000582435",
                    "term": "Pembrolizumab"
                },
                {
                    "id": "D000069287",
                    "term": "Capecitabine"
                },
                {
                    "id": "D000077150",
                    "term": "Oxaliplatin"
                },
                {
                    "id": "D000005472",
                    "term": "Fluorouracil"
                },
                {
                    "id": "D000068878",
                    "term": "Trastuzumab"
                },
                {
                    "id": "C000613593",
                    "term": "Durvalumab"
                },
                {
                    "id": "C000614160",
                    "term": "Trastuzumab deruxtecan"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000964",
                    "term": "Antimetabolites, Antineoplastic"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018796",
                    "term": "Immunoconjugates"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "asFound": "Mg/m2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M272500",
                    "name": "Durvalumab",
                    "asFound": "Pancreatic",
                    "relevance": "HIGH"
                },
                {
                    "id": "M377",
                    "name": "Capecitabine",
                    "asFound": "200",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1674",
                    "name": "Oxaliplatin",
                    "asFound": "Min",
                    "relevance": "HIGH"
                },
                {
                    "id": "M325",
                    "name": "Trastuzumab",
                    "asFound": "Follow-up",
                    "relevance": "HIGH"
                },
                {
                    "id": "M233243",
                    "name": "Trastuzumab deruxtecan",
                    "asFound": "Tilt",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8600",
                    "name": "Fluorouracil",
                    "asFound": "According",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6182",
                    "name": "Cisplatin",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20855",
                    "name": "Immunoconjugates",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}